...
crdl-img

Cardiol Therapeutics Inc Class A, Common Stock

CRDL

NAQ

$1.31

-$0.03

(-2.24%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$111.80M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
472.08K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.70
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.79 L
$3.12 H
$1.31

About Cardiol Therapeutics Inc Class A, Common Stock

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCRDLSectorS&P500
1-Week Return-3.68%-3.35%-2.97%
1-Month Return-20.61%-3.49%-0.66%
3-Month Return-41.78%-12.6%2.71%
6-Month Return-30.69%-6.91%7.21%
1-Year Return51.8%1.19%23.04%
3-Year Return-33.84%-0.21%28.43%
5-Year Return-57.33%33.09%82.88%
10-Year Return-64.99%93.55%184.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-78.76K78.76K--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue150.57K229.54K-219.91K248.35K[{"date":"2019-12-31","value":60.63,"profit":true},{"date":"2020-12-31","value":92.42,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":88.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(150.57K)(229.54K)78.76K(219.91K)(248.35K)[{"date":"2019-12-31","value":-191.18,"profit":false},{"date":"2020-12-31","value":-291.44,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-279.21,"profit":false},{"date":"2023-12-31","value":-315.33,"profit":false}]
Gross Margin(Infinity%)(291.44%)100.00%(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":-291.44,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses14.13M20.69M38.74M41.34M29.79M[{"date":"2019-12-31","value":34.18,"profit":true},{"date":"2020-12-31","value":50.05,"profit":true},{"date":"2021-12-31","value":93.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":72.06,"profit":true}]
Operating Income(13.58M)(20.61M)(45.47M)(50.34M)(29.79M)[{"date":"2019-12-31","value":-1358355200,"profit":false},{"date":"2020-12-31","value":-2060648000,"profit":false},{"date":"2021-12-31","value":-4547312800,"profit":false},{"date":"2022-12-31","value":-5033903400,"profit":false},{"date":"2023-12-31","value":-2978550400,"profit":false}]
Total Non-Operating Income/Expense443.75K42.13K7.13M11.64M3.83M[{"date":"2019-12-31","value":3.81,"profit":true},{"date":"2020-12-31","value":0.36,"profit":true},{"date":"2021-12-31","value":61.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.91,"profit":true}]
Pre-Tax Income(13.68M)(20.64M)(31.64M)(30.93M)(28.13M)[{"date":"2019-12-31","value":-1368402300,"profit":false},{"date":"2020-12-31","value":-2064093500,"profit":false},{"date":"2021-12-31","value":-3163824400,"profit":false},{"date":"2022-12-31","value":-3093064700,"profit":false},{"date":"2023-12-31","value":-2812829100,"profit":false}]
Income Taxes299.42K7.40K(6.91M)(10.24M)5.00[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":2.47,"profit":true},{"date":"2021-12-31","value":-2309.27,"profit":false},{"date":"2022-12-31","value":-3420.25,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(13.98M)(20.65M)(24.72M)(20.69M)(28.13M)[{"date":"2019-12-31","value":-1398343900,"profit":false},{"date":"2020-12-31","value":-2064833300,"profit":false},{"date":"2021-12-31","value":-2472391600,"profit":false},{"date":"2022-12-31","value":-2068985900,"profit":false},{"date":"2023-12-31","value":-2812829600,"profit":false}]
Income From Continuous Operations(13.68M)(20.64M)(31.64M)(30.93M)(28.01M)[{"date":"2019-12-31","value":-1368402300,"profit":false},{"date":"2020-12-31","value":-2064093500,"profit":false},{"date":"2021-12-31","value":-3163824400,"profit":false},{"date":"2022-12-31","value":-3093064700,"profit":false},{"date":"2023-12-31","value":-2800629300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(13.68M)(20.64M)(31.64M)(30.93M)(28.13M)[{"date":"2019-12-31","value":-1368402300,"profit":false},{"date":"2020-12-31","value":-2064093500,"profit":false},{"date":"2021-12-31","value":-3163824400,"profit":false},{"date":"2022-12-31","value":-3093064700,"profit":false},{"date":"2023-12-31","value":-2812829100,"profit":false}]
EPS (Diluted)(0.41)(0.46)(0.71)(0.49)(0.41)[{"date":"2019-12-31","value":-41.01,"profit":false},{"date":"2020-12-31","value":-46.21,"profit":false},{"date":"2021-12-31","value":-70.97,"profit":false},{"date":"2022-12-31","value":-49,"profit":false},{"date":"2023-12-31","value":-41,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CRDL
Cash Ratio 2.28
Current Ratio 2.49

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CRDL
ROA (LTM) -54.15%
ROE (LTM) -108.44%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CRDL
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CRDL
Trailing PE NM
Forward PE NM
P/S (TTM) 1069.35
P/B 14.95
Price/FCF NM
EV/R 178.81
EV/Ebitda 0.30

FAQs

What is Cardiol Therapeutics Inc Class A share price today?

Cardiol Therapeutics Inc Class A (CRDL) share price today is $1.31

Can Indians buy Cardiol Therapeutics Inc Class A shares?

Yes, Indians can buy shares of Cardiol Therapeutics Inc Class A (CRDL) on Vested. To buy Cardiol Therapeutics Inc Class A from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CRDL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cardiol Therapeutics Inc Class A be purchased?

Yes, you can purchase fractional shares of Cardiol Therapeutics Inc Class A (CRDL) via the Vested app. You can start investing in Cardiol Therapeutics Inc Class A (CRDL) with a minimum investment of $1.

How to invest in Cardiol Therapeutics Inc Class A shares from India?

You can invest in shares of Cardiol Therapeutics Inc Class A (CRDL) via Vested in three simple steps:

  • Click on Sign Up or Invest in CRDL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cardiol Therapeutics Inc Class A shares
What is Cardiol Therapeutics Inc Class A 52-week high and low stock price?

The 52-week high price of Cardiol Therapeutics Inc Class A (CRDL) is $3.12. The 52-week low price of Cardiol Therapeutics Inc Class A (CRDL) is $0.79.

What is Cardiol Therapeutics Inc Class A price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cardiol Therapeutics Inc Class A (CRDL) is

What is Cardiol Therapeutics Inc Class A price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cardiol Therapeutics Inc Class A (CRDL) is 14.95

What is Cardiol Therapeutics Inc Class A dividend yield?

The dividend yield of Cardiol Therapeutics Inc Class A (CRDL) is 0.00%

What is the Market Cap of Cardiol Therapeutics Inc Class A?

The market capitalization of Cardiol Therapeutics Inc Class A (CRDL) is $111.80M

What is Cardiol Therapeutics Inc Class A’s stock symbol?

The stock symbol (or ticker) of Cardiol Therapeutics Inc Class A is CRDL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top